IPP Bureau

Glenmark Pharmaceuticals USA reaches antitrust settlement with DOJ
Glenmark Pharmaceuticals USA reaches antitrust settlement with DOJ

By IPP Bureau - August 24, 2023

The company has entered into a three-year Deferred Prosecution Agreement

Briefs: J B Chemicals & Pharmaceuticals updates and Torrent Pharmaceuticals
Briefs: J B Chemicals & Pharmaceuticals updates and Torrent Pharmaceuticals

By IPP Bureau - August 24, 2023

The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat

NIH and Exothera partner to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US
NIH and Exothera partner to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US

By IPP Bureau - August 24, 2023

NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials

First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl
First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl

By IPP Bureau - August 24, 2023

Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl

Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation
Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation

By IPP Bureau - August 24, 2023

Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country

Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets
Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets

By IPP Bureau - August 23, 2023

Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences
Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences

By IPP Bureau - August 23, 2023

Eris Lifesciences enters into term loan agreement with Citi Bank

Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round
Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round

By IPP Bureau - August 23, 2023

Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO

LEO Pharma to acquire Timber Pharmaceuticals
LEO Pharma to acquire Timber Pharmaceuticals

By IPP Bureau - August 22, 2023

The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million

Former Bayer Pharma CEO Dieter Weinand joins Coya’s Board of Directors
Former Bayer Pharma CEO Dieter Weinand joins Coya’s Board of Directors

By IPP Bureau - August 22, 2023

Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business

Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
Shiva Pharmachem files DRHP for its Rs. 900 crore IPO

By IPP Bureau - August 22, 2023

The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment

Jiangsu Hengrui Pharmaceuticals gets NMPA approval of oteseconazole Ccapsules
Jiangsu Hengrui Pharmaceuticals gets NMPA approval of oteseconazole Ccapsules

By IPP Bureau - August 22, 2023

Oteseconazole Capsules were found to be safe and more effective than fluconazole

EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema
EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema

By IPP Bureau - August 21, 2023

LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment

Venus Remedies launches its flagship R&D drug Elores in Oman
Venus Remedies launches its flagship R&D drug Elores in Oman

By IPP Bureau - August 21, 2023

The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025

Dr. Reddy's appoints Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign
Dr. Reddy's appoints Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign

By IPP Bureau - August 21, 2023

The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle

Latest Stories

Interviews

Packaging